Cardiomyopathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
{{Cardiomyopathy}} | {{Cardiomyopathy}} | ||
{{CMG}}; | {{CMG}}; {{AE}} {{CZ}}, {{RT}} | ||
==[[Cardiomyopathy overview|Overview]]== | ==[[Cardiomyopathy overview|Overview]]== | ||
| Line 27: | Line 25: | ||
==[[Cardiomyopathy pathophysiology|Pathophysiology]]== | ==[[Cardiomyopathy pathophysiology|Pathophysiology]]== | ||
==[[Cardiomyopathy epidemiology and demographics|Epidemiology | ==[[Cardiomyopathy epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Cardiomyopathy risk factors|Risk Factors]]== | ==[[Cardiomyopathy risk factors|Risk Factors]]== | ||
==[[Cardiomyopathy causes|Causes | ==[[Cardiomyopathy causes|Causes]]== | ||
:[[Dilated cardiomyopathy]] | :[[Dilated cardiomyopathy]] | ||
:[[Hypertrophic obstructive cardiomyopathy]] | :[[Hypertrophic obstructive cardiomyopathy]] | ||
| Line 39: | Line 37: | ||
==[[Cardiomyopathy differential diagnosis|Differentiating Cardiomyopathy from other Diseases]]== | ==[[Cardiomyopathy differential diagnosis|Differentiating Cardiomyopathy from other Diseases]]== | ||
==[[Cardiomyopathy natural history|Natural History, Complications | ==[[Cardiomyopathy natural history|Natural History, Complications and Prognosis]]== | ||
==Treatment== | ==Treatment== | ||
| Line 68: | Line 66: | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Up-To-Date cardiology]] | [[Category:Up-To-Date cardiology]] | ||
[[Category:Disease]] | |||
Revision as of 14:38, 30 August 2012
For patient information click here
| Cardiomyopathy | |
 | |
|---|---|
| Opened left ventricle of heart shows a thickened, dilated left ventricle with subendocardial fibrosis manifested as increased whiteness of endocardium {Autopsy findings}. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | I42.0 |
| ICD-9 | 425.4 |
| DiseasesDB | 2137 |
| MeSH | D009202 |
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Raviteja Guddeti, M.B.B.S. [3]
Overview
Classification
Pathophysiology
Epidemiology and Demographics
Risk Factors
Causes
- Dilated cardiomyopathy
- Hypertrophic obstructive cardiomyopathy
- Noncompaction cardiomyopathy
- Tachycardia induced cardiomyopathy
Differentiating Cardiomyopathy from other Diseases
Natural History, Complications and Prognosis
Treatment
External links
de:Kardiomyopathie nl:Cardiomyopathie no:Kardiomyopati simple:Cardiomyopathy sr:Кардиомиопатија sv:Hjärtmuskelsjukdom